INHIBITION OF FRUSEMIDE-INDUCED HYPERRENINÆMIA BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN MAN
- 1 April 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 307 (7963), 772-774
- https://doi.org/10.1016/s0140-6736(76)91611-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Long-term Infusion of Growth Hormone Release Inhibiting Hormone in Acromegaly: Effects on Pituitary and Pancreatic HormonesBMJ, 1974
- Effect of Somatostatin on Plasma Glucose and Insulin Responses to Glucagon and Tolbutamide in ManJournal of Clinical Endocrinology & Metabolism, 1974
- Somatostatin-Induced Changes in Insulin and Glucagon Secretion in Normal and Diabetic DogsJCI Insight, 1974
- Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patientsMetabolism, 1974
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974
- Inhibition of Pancreatic Glucagon Responses to Arginine by Somatostatin in Normal Man and in Insulin-Dependent DiabeticsDiabetes, 1974
- GLUCAGON CONTROL OF FASTING GLUCOSE IN MANThe Lancet, 1974
- Somatostatin: Hypothalamic Inhibitor of the Endocrine PancreasScience, 1974
- EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE ON CIRCULATING GLUCAGON, INSULIN, AND GROWTH HORMONE IN NORMAL, DIABETIC, ACROMEGALIC, AND HYPOPITUITARY PATIENTSThe Lancet, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973